Creative Planning
AGN.PRA

Creative Planning’s Allergan plc AGN.PRA Stock Holding History

Creative Planning’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20
Closed -$17K – 4472
2017
Q2 		$17K Hold
20
– – ﹤0.01% 3300
2017
Q1 		$17K Hold
20
– – ﹤0.01% 3252
2016
Q4 		$15K Hold
20
– – ﹤0.01% 3292
2016
Q3 		$16K Buy
+20
New +$17.3K ﹤0.01% 3224
2016
Q2 		– Sell
-5
Closed -$5K – 4639
2016
Q1 		$5K Hold
5
– – ﹤0.01% 3640
2015
Q4 		$5K Buy
+5
New +$5.02K ﹤0.01% 3735

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Creative Planning's AGN.PRA Position: Q3 2017 in Review

Creative Planning sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 20 shares — an estimated $17K sold.

Creative Planning first reported a position in AGN.PRA in Q4 2015 and held it in 6 quarters. The position peaked at $17K in Q2 2017. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

  • Creative Planning reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 20 Allergan plc shares in Q3 2017, an estimated $17K.
  • Creative Planning first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
  • Creative Planning's Allergan plc position peaked at $17K in Q2 2017.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.